互补还是替代？更强与更弱的整合政策。

Complementary or alternative? Stronger vs weaker integration policies.

作者信息

Hess David J

机构信息

Science and Technology Studies Department, Rensselaer Polytechnic Institute, 110 8th Street, Sage Building 5th Floor, Troy, NY 12180-3590, USA.

出版信息

Am J Public Health. 2002 Oct;92(10):1579-81. doi: 10.2105/ajph.92.10.1579.

DOI:10.2105/ajph.92.10.1579

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1447283/

Abstract

Scientific research is particularly important as a guide to health care policy regarding the "integration" of complementary and alternative medicine (CAM) into conventional medical practices. A spectrum of possibilities has emerged around the question of balancing integration toward complementary vs alternative usages. Although scientific research can guide policies and practices, it has become subject to greater scrutiny and linked to differences on policy issues. Using CAM cancer therapies as a case study, this commentary explores relationships between methodology and policy regarding the integration of CAM therapies.

摘要

作为将补充和替代医学（CAM）“整合”到传统医疗实践中的医疗保健政策指南，科学研究尤为重要。围绕着平衡向补充性与替代性用途整合的问题，出现了一系列可能性。尽管科学研究可以指导政策和实践，但它受到了更严格的审查，并与政策问题上的分歧联系在一起。本评论以CAM癌症疗法为例，探讨了CAM疗法整合方面的方法与政策之间的关系。

相似文献

1

Complementary or alternative? Stronger vs weaker integration policies.

Am J Public Health. 2002 Oct;92(10):1579-81. doi: 10.2105/ajph.92.10.1579.

2

New opportunities and proven approaches in complementary and alternative medicine research at the National Institutes of Health.

J Altern Complement Med. 2001;7 Suppl 1:S53-9. doi: 10.1089/107555301753393814.

3

Research on complementary and alternative medicine using randomized controlled trials.

J Altern Complement Med. 2001;7 Suppl 1:S45-52. doi: 10.1089/107555301753393805.

4

The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.

J Am Coll Radiol. 2009 Apr;6(4):254-62. doi: 10.1016/j.jacr.2008.09.012.

5

Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.

J Clin Oncol. 2005 Sep 20;23(27):6682-9. doi: 10.1200/JCO.2005.10.728.

6

NCCAM support for the Cochrane Collaboration CAM Field.

Complement Ther Med. 2003 Dec;11(4):268-71. doi: 10.1016/s0965-2299(03)00128-6.

7

Complementary and alternative medicine research: a National Cancer Institute perspective.

Semin Oncol. 2002 Dec;29(6):546-51. doi: 10.1053/sonc.2002.50003.

8

The National Cancer Institute's perspective and agenda for promoting awareness and research on alternative therapies for cancer.

J Altern Complement Med. 2002 Oct;8(5):545-50. doi: 10.1089/107555302320825048.

9

Science and government. Enhanced: in defense of NCCAM.

Science. 2006 Jul 21;313(5785):303-4. doi: 10.1126/science.1131608.

10

CAM research in Britain: the last 10 years.

Complement Ther Clin Pract. 2005 Feb;11(1):17-20. doi: 10.1016/j.ctnm.2004.09.005.

引用本文的文献

1

The influence of social context on the treatment outcomes of complementary and alternative medicine: the case of acupuncture and herbal medicine in Japan and the U.S.

Global Health. 2015 Apr 25;11:17. doi: 10.1186/s12992-015-0103-2.

本文引用的文献

1

Randomized, controlled trials, observational studies, and the hierarchy of research designs.

N Engl J Med. 2000 Jun 22;342(25):1887-92. doi: 10.1056/NEJM200006223422507.

2

A comparison of observational studies and randomized, controlled trials.

N Engl J Med. 2000 Jun 22;342(25):1878-86. doi: 10.1056/NEJM200006223422506.

3

Five-year survival rates of melanoma patients treated by diet therapy after the manner of Gerson: a retrospective review.

Altern Ther Health Med. 1995 Sep;1(4):29-37.

4

Advising patients who seek alternative medical therapies.

Ann Intern Med. 1997 Jul 1;127(1):61-9. doi: 10.7326/0003-4819-127-1-199707010-00010.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。